Sort   by:  
 Page size 
UnknownSimulation and Prediction of the Drug-Drug Interaction Potential of Naloxegol by Physiologically Based Pharmacokinetic Modeling.
Not available
S-EPMC4879473 | biostudies-literature
UnknownDevelopment and Utilization of a Palladium-Catalyzed Dehydration of Primary Amides To Form Nitriles.
Not available
S-EPMC6179452 | biostudies-literature
UnknownPopulation pharmacokinetic and exposure simulation analysis for cediranib (AZD2171) in pooled Phase I/II studies in patients with cancer.
Not available
S-EPMC5510068 | biostudies-literature
UnknownModeling Tumor Growth and Treatment Resistance Dynamics Characterizes Different Response to Gefitinib or Chemotherapy in Non-Small Cell Lung Cancer.
Not available
S-EPMC7080537 | biostudies-literature
UnknownResistance models to EGFR inhibition and chemotherapy in non-small cell lung cancer via analysis of tumour size dynamics.
Not available
S-EPMC6561994 | biostudies-literature
UnknownPopulation pharmacokinetics of naloxegol in a population of 1247 healthy subjects and patients.
Not available
S-EPMC4693583 | biostudies-literature
UnknownPopulation exposure-safety analysis of cediranib for Phase I and II studies in patients with cancer.
Not available
S-EPMC5867133 | biostudies-literature
UnknownPopulation pharmacokinetics modeling and exposure-response analyses of cemiplimab in patients with recurrent or metastatic cervical cancer.
Not available
S-EPMC9662200 | biostudies-literature
UnknownPopulation pharmacokinetics and exposure-response modeling for evinacumab in homozygous familial hypercholesterolemia.
Not available
S-EPMC8592514 | biostudies-literature
UnknownPopulation Exposure-Response Modeling of Naloxegol in Patients With Noncancer-Related Pain and Opioid-Induced Constipation.
Not available
S-EPMC4961079 | biostudies-literature
Sort   by:  
 Page size